European Companies Search Engine
Managing Director (1) · No longer Managing Director (1) · Shareholder agreement · Corporate Purpose · Subsidiary Hrb26 Feb 2008 German Trade Register Announcements, Germany (20/02/2008)
Overview
Text
Institut für molekulare Diagnostik und innovative Therapie - Molthera - GmbH, Witten (
Unnamed street ??, 58452 Witten, Germany
). The Shareholders' Meeting of December 13, 2007 decided to amend the partnership agreement. New corporate item: Execution of molecular diagnostics in medicine and dentistry with a focus on chronic inflammation. Use of Internet platforms to distribute molecular diagnostic products in medicine and dentistry with a focus on chronic inflammation. Research and development in the field of molecular diagnostics in medicine and dentistry as well as the introduction of innovative therapies with a focus on chronic inflammation. The company is entitled to participate in companies, to acquire such companies or to set up new ones. The company may also set up branches. The Company is further entitled to carry out all other transactions and measures that are suitable for the purpose of the company and are suitable for promoting it. It is entitled to operate a manufacturing industry in the field of medicine - in vitro cell culture, ex vivo cell culture, molecular biology diagnostics and dental CAD/CAM methods. No longer Managing Director: Prof. Dr. ???????????, ????, Bochum, *??.??.????. Appointed as Managing Director: Prof. Dr. rer. ???????, ??????, Bochum, *??.??.???? to enter into legal transactions on behalf of the company in its own name or a.s. a representative of a third party.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Institut für molekulare Diagnostik und innovative Therapie - Molthera - GmbH, Bayerisch Gmain, Germany.